Kasper Lamberth MSc, PhD

Dr. H. Kaspar Binz is Vice President and co-founder of Molecular Partners (SIX: MOLN), a Swiss clinical stage biotech company developing DARPin drugs for therapeutic applications. With his entrepreneurial approach Dr. Binz was key in the establishment of Molecular Partners as a successful biotech company, and in the establishment of Molecular Partners’ Pipeline. He invented and developed the designed repeat protein technology including the DARPin technology during his post-doctoral training and PhD studies with Prof. Andreas Plückthun at the University of Zurich, Switzerland.
Dr. Binz has published widely in the areas of protein engineering and drug development and is inventor on numerous patents and patent applications. His research and entrepreneurial spirit have been awarded with several prizes including the Swiss Technology Award 2005, the Swiss Venture 2004 business plan competition award, and the De Vigier Foundation award 2005. He serves as scientific advisor to several protein engineering conferences and has presented his work at numerous international science conferences. Dr. Binz was educated at the Royal Institute of Technology in Stockholm, Sweden (Prof. Mathias Uhlen) and holds a M.Sc. in biotechnology from the European school of biotechnology in Strasbourg, France.